Today’s Solutions: October 24, 2026

The next time you tweak your back, think twice before heading to the medicine cabinet. Acetaminophen, best known as the active ingredient in Tylenol, is the most popular drug in the world for treating low back pain. But a new study shows that it doesn’t help any more than a placebo, or inert sugar pill, for getting rid of the pain.

Researchers in Australia divided over 1,600 people with low back pain into three groups: regular dosing with acetaminophen, as-needed dosing, and dosing with a placebo. In addition to measuring how long it took for the participants’ back pain to clear up, they also measured overall pain levels and participants’ ability to function, sleep, and their quality of life. Across the board, they saw no differences between the three groups—taking acetaminophen regularly or only when in pain had no effect on how the participants felt or how long they needed to recover.

These findings, published in the prestigious Lancet medical journal, undermine existing medical guidelines—which recommend acetaminophen as the first-choice drug for back pain.

(Source: The Lancet, 2014; DOI: 10.1016/S0140-6736(14)60805-9)

Print this article
More of Today's Solutions

4 simple ways to feel at your absolute best this summer

The sunshine of summer is enough to make you feel better than you usually do throughout the year. But with a few changes to ...

Read More

Simple tips for making homemade fertilizer

Making fertilizer at home is a great option for home gardeners who want to find ways to repurpose their waste and reduce their consumption ...

Read More

Australian study reveals a low-cost strategy for recycling solar panels

A new study has proposed a low-cost method of recycling solar panels to help handle the growing volume of retired photovoltaic (PV) cells expected ...

Read More

Brilliant green comet makes rare appearance—and it won’t return for 1.4 milli...

BY THE OPTIMIST DAILY EDITORIAL TEAM Every so often, the cosmos offers a rare spectacle that feels timeless yet brand new. This spring, that ...

Read More